Varicella-Zoster Virus (VZV)-Specific Cytotoxicity after Immunization of Nonimmune Adults with Oka Strain Attenuated VZV Vaccine

Journal of Infectious Diseases

Volumn 166, Issue 2, 1992, Pages 260-264

  Hayward, Anthony ^a   Villanueba, Eileen ^a   Cosyns, Mary ^a   Levin, Myron ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN G; RECOMBINANT INTERLEUKIN 2; VARICELLA ZOSTER VACCINE; VIRUS ANTIGEN;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS;

ADULT; ANTIBODIES, VIRAL; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHICKENPOX VACCINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 3, HUMAN; HUMAN; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0026691380     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/166.2.260     Document Type: Article

References (19)

1. Arvin A. Clinical manifestations of varicella and herpes zoster and the immune response to varicella-zoster virus. In: Hyman RW, ed. Natural history of varicella-zoster virus. Boca Raton, FL: CRC Press, 1987:67-130.
2. Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer. Pediatrics 1975;56:388-97.
3. Balfour HH. Varicella-zoster virus infections in immunocompromised hosts. Am J Med 1988;85(suppl 2A)68-72.
4. Takahashi M. A vaccine to prevent chickenpox. In: Hyman RW. ed. Natural history of varicella-zoster virus. Boca Raton. FL: CRC Press, 1987:180-206.
5. Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 1989;320:892-7.
6. Ndumbe PM, Cradock Watson J, Levinsky RJ. Natural and artificial immunity to varicella-zoster virus. J Med Virol 1988;25:171-8.
7. Johnson C, Rome LP, Stancin T, Kumar ML. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 1989;84:418-21.
8. Bergen RE, Diaz PS, Arvin AM. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. J Infect Dis 1990;162:1049-54.
9. Diaz PS, Smith S, Hunter E, Arvin AM. T-lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella zoster virus vaccine. J Immunol 1989; 142:636-41.
10. Hayward AR, Giller R, Levin M. Phenotype, cytotoxicity and helper functions of T cells from varicella-zoster virus stimulated cultures of human lymphocytes. Viral Immunol 1989;2:175-82.
11. Hayward AR, Herberger M. Lymphocyte responses to varicella-zoster virus in the elderly. J Clin Immunol 1987;7:174-8.
12. Zaia JA, Leary PL, Levin MJ. Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun 1978;20:646-72.
13. Takahashi M, Okuno Y, Otsuka T, et al. Development of a live attenuated varicella vaccine. Biken J 1975;18:25-33.
14. Hayward AR, Pontesilli O, Herberger M, Laszlo M, Levin M. Specific lysis of VZV infected B lymphoblasts by human T cells. J Virol 1986;58:179-84.
15. Edson CM, Hosier BA, Respess RA, Waters DJ, Thorley-Lawson D. Cross-reactivity between herpes simplex virus glycoprotein B and a 63, 000-dalton varicella-zoster virus envelope glycoprotein. J Virol 1985;56:333-6.
16. Wieraga EA, Snoek M, Jansen HM, Bos JD, van Lier RAW, Kapsen-berg ML. Human atopen-specific types I and 2 helper cell clones. J Immunol 1991;147:2942-9.
17. + or CD8 phenotype. J Immunol 1991;146:257-64.
18. Hayward AR, Burger R, Scheper R, Arvin AM. MHC restriction of T cell responses to varicella zoster virus in guinea pigs. J Virol 1991;65:1491-5.
19. Bowden RA, McGavren L. Hayward AR, Levin MJ. Use of bone marrow fibroblasts to prepare targets for an HLA restricted cytotoxicity assay system. J Clin Microbiol 1984;20:696-700.